- Home
- A-Z Publications
- Mini Reviews in Medicinal Chemistry
- Previous Issues
- Volume 24, Issue 19, 2024
Mini Reviews in Medicinal Chemistry - Volume 24, Issue 19, 2024
Volume 24, Issue 19, 2024
-
-
The Indispensable Roles of GMDS and GMDS-AS1 in the Advancement of Cancer: Fucosylation, Signal Pathway and Molecular Pathogenesis
Authors: Ziyan Zhang, Zhuowei Wang, Hong Fan, Jiayi Li, Jiaqi Ding, Gang Zhou and Chengfu YuanFucosylation is facilitated by converting GDP-mannose to GDP-4-keto-6-deoxymannose, which GDP-mannose 4,6-dehydratase, a crucial enzyme in the route, carries out. One of the most prevalent glycosylation alterations linked to cancer has reportedly been identified as fucosylation. There is mounting evidence that GMDS is intimately linked to the onset and spread of cancer. Furthermore, the significance of long-chain non-co Read More
-
-
-
Nanoparticle-based Gene Therapy for Neurodegenerative Disorders
Authors: Nelofer Ereej, Huma Hameed, Mahtab A. Khan, Saleha Faheem and Anam HameedNeurological disorders present a formidable challenge in modern medicine due to the intricate obstacles set for the brain and the multipart nature of genetic interventions. This review article delves into the promising realm of nanoparticle-based gene therapy as an innovative approach to addressing the intricacies of neurological disorders. Nanoparticles (NPs) provide a multipurpose podium for the conveyance of therapeu Read More
-
-
-
Structural Perspectives in the Development of Novel EGFR Inhibitors for the Treatment of NSCLC
Authors: Rahul Makhija, Anushka Sharma, Rahul Dubey and Vivek AsatiNon-small cell Lung cancer (NSCLC) is the most common type of lung cancer, which is caused by high consumption of tobacco and smoking. It is an epithelial lung cancer that affects about 2.2 million people across the globe, according to International Agency for Research on Cancer (IARC). Non-small cell lung cancer is a malignant tumor caused by EGFR mutation that occurs in the in-frame deletion of exon 19 and L858R point m Read More
-
-
-
Aloe-emodin: Progress in Pharmacological Activity, Safety, and Pharmaceutical Formulation Applications
Authors: Haimeng Luo, Xiaoyun Ji, Mengyu Zhang, Yaoyao Ren, Rui Tan, Hezhong Jiang and Xiaoqing WuAloe-emodin (AE) is an anthraquinone derivative and a biologically active component sourced from various plants, including Rheum palmatum L. and Aloe vera. Known chemically as 1,8-dihydroxy-3-hydroxymethyl-anthraquinone, AE has a rich history in traditional medicine and is esteemed for its accessibility, safety, affordability, and effectiveness. AE boasts multiple biochemical and pharmacological properties, such as stro Read More
-
Volumes & issues
-
Volume 25 (2025)
-
Volume 24 (2024)
-
Volume 23 (2023)
-
Volume 22 (2022)
-
Volume 21 (2021)
-
Volume 20 (2020)
-
Volume 19 (2019)
-
Volume 18 (2018)
-
Volume 17 (2017)
-
Volume 16 (2016)
-
Volume 15 (2015)
-
Volume 14 (2014)
-
Volume 13 (2013)
-
Volume 12 (2012)
-
Volume 11 (2011)
-
Volume 10 (2010)
-
Volume 9 (2009)
-
Volume 8 (2008)
-
Volume 7 (2007)
-
Volume 6 (2006)
-
Volume 5 (2005)
-
Volume 4 (2004)
-
Volume 3 (2003)
-
Volume 2 (2002)
-
Volume 1 (2001)
Most Read This Month
Article
content/journals/mrmc
Journal
10
5
false
en
